Arwa Ali

831 total citations
34 papers, 620 citations indexed

About

Arwa Ali is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arwa Ali has authored 34 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arwa Ali's work include Cancer Immunotherapy and Biomarkers (8 papers), Renal cell carcinoma treatment (5 papers) and Cancer Risks and Factors (4 papers). Arwa Ali is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Renal cell carcinoma treatment (5 papers) and Cancer Risks and Factors (4 papers). Arwa Ali collaborates with scholars based in Saudi Arabia, Egypt and United Kingdom. Arwa Ali's co-authors include John R. Goffin, Peter Ellis, Andrew Arnold, Khalid Alsaleh, Abdullah Aldahmash, Nehad M. Alajez, Rimi Hamam, Moustapha Kassem, Ellen Warner and Asmaa M. Zahran and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Arwa Ali

32 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arwa Ali Saudi Arabia 12 304 237 209 207 77 34 620
Idoroenyi Amanam United States 8 529 1.7× 200 0.8× 264 1.3× 215 1.0× 108 1.4× 31 795
Anne Uyei United States 9 559 1.8× 303 1.3× 111 0.5× 88 0.4× 149 1.9× 15 771
Kuniko Sunami Japan 16 320 1.1× 150 0.6× 196 0.9× 297 1.4× 42 0.5× 47 638
Ratislav Bahleda France 12 218 0.7× 168 0.7× 114 0.5× 128 0.6× 33 0.4× 31 458
W. Li China 11 684 2.3× 372 1.6× 191 0.9× 337 1.6× 104 1.4× 47 981
Tareq Al Baghdadi United States 12 415 1.4× 196 0.8× 175 0.8× 217 1.0× 53 0.7× 35 593
Smitha Menon United States 11 300 1.0× 134 0.6× 73 0.3× 128 0.6× 75 1.0× 18 474
Yoojoo Lim South Korea 14 201 0.7× 162 0.7× 127 0.6× 117 0.6× 30 0.4× 56 485
Moshe Mishaeli Israel 9 357 1.2× 248 1.0× 117 0.6× 253 1.2× 34 0.4× 27 591

Countries citing papers authored by Arwa Ali

Since Specialization
Citations

This map shows the geographic impact of Arwa Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arwa Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arwa Ali more than expected).

Fields of papers citing papers by Arwa Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arwa Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arwa Ali. The network helps show where Arwa Ali may publish in the future.

Co-authorship network of co-authors of Arwa Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Arwa Ali. A scholar is included among the top collaborators of Arwa Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arwa Ali. Arwa Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beddok, Arnaud, Guillaume Breton, Arwa Ali, et al.. (2025). Enhancing Expertise in Reirradiation: Results from a Training Workshop Organized by Unicancer, the Federation of French Cancer Centers. Journal of Cancer Education. 40(6). 987–992.
2.
Ali, Arwa, et al.. (2024). Cancer and Syria in conflict: a systematic review. BMC Cancer. 24(1). 1537–1537. 6 indexed citations
3.
Ibrahim, Mohamed Izham Mohamed, et al.. (2023). Perception of consanguineous marriage among the qatari population. Frontiers in Public Health. 11. 1228010–1228010. 3 indexed citations
4.
Ali, Arwa, Menghan Gao, Hai Wang, et al.. (2023). Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment. Frontiers in Immunology. 14. 1146413–1146413. 2 indexed citations
6.
Elango, Ramesh, Khalid Alsaleh, Radhakrishnan Vishnubalaji, et al.. (2020). MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM. Frontiers in Oncology. 10. 756–756. 36 indexed citations
7.
Alsaleh, Khalid, et al.. (2019). A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC).. PubMed. 1(30). 33–42. 4 indexed citations
8.
Burnett, Alan K., Robert K. Hills, Olav Wendelboe Nielsen, et al.. (2018). A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial. Leukemia. 32(12). 2693–2697. 12 indexed citations
9.
Farrag, Ashraf, et al.. (2018). Rare Case of Intracardiac Renal Cell Carcinoma Metastasis with Response to Nivolumab: Case Report and Literature Review. Case Reports in Oncology. 11(3). 861–870. 11 indexed citations
10.
Ali, Muhammad, et al.. (2017). Concurrent immuno-radiotherapy in lung and renal cancer- a new treatment paradigm. Annals of Oncology. 28. v424–v424. 1 indexed citations
11.
Alsaleh, Khalid, Arwa Ali, Jawaher Ansari, et al.. (2017). Predictive and prognostic significance of CD8+ tumor-infiltrating lymphocytes in patients with luminal B/HER 2 negative breast cancer treated with neoadjuvant chemotherapy. Oncology Letters. 14(1). 337–344. 30 indexed citations
12.
Zahran, Asmaa M., et al.. (2016). Circulating endothelial cells and their progenitors in acute myeloid leukemia. Oncology Letters. 12(3). 1965–1970. 8 indexed citations
13.
Ali, Arwa, et al.. (2016). Triple Negative Breast Cancer: A Tale of Two Decades. Anti-Cancer Agents in Medicinal Chemistry. 17(4). 491–499. 36 indexed citations
14.
Hamam, Rimi, Arwa Ali, Khalid Alsaleh, et al.. (2016). microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection. Scientific Reports. 6(1). 25997–25997. 126 indexed citations
16.
Alamri, Fahad, et al.. (2015). Breast cancer correlates in a cohort of breast screening program participants in Riyadh, KSA. Journal of the Egyptian National Cancer Institute. 27(2). 77–82. 7 indexed citations
17.
Ali, Arwa, John R. Goffin, Andrew Arnold, & Peter Ellis. (2013). Survival of Patients with Non-Small-Cell Lung Cancer after a Diagnosis of Brain Metastases. Current Oncology. 20(4). 300–306. 176 indexed citations
18.
Ali, Arwa & Ellen Warner. (2013). PYNK : Breast Cancer Program for Young Women. Current Oncology. 20(1). 34–39. 28 indexed citations
19.
Ali, Arwa, Takayuki Ueno, Sunao Tanaka, et al.. (2011). Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients. European Journal of Cancer. 47(15). 2265–2272. 26 indexed citations
20.
Ali, Arwa, Makoto Toi, & Takayuki Ueno. (2009). Anti-Angiogenic Cancer Therapy Updates. Current Molecular Medicine. 9(8). 954–966. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026